Zurueck zur Suche

Reporte zur Charge UJ757AAA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

3Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
CA 1 MA 1 NV 1

VAERS 2659073

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge UJ757AAA

gering
Staat
CA
Alter
0,5
Geschlecht
F
Eingang
20.07.2023
Impfdatum
17.07.2023
Beginn
17.07.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

pentacel was administered to a patient after it experienced a temperature excursion with no reported adverse event; Initial information was received on 18-Jul-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 7 months old female patient who received diphtheria/tetanus/5 hybrid ac pertussis/ipv(vero)/hib(prp/t) vaccine [Pentacel (vero)] after it experienced a temperature excursion with no reported adverse event. The patient's past medical history, medical treatment(s), concomitant medications, vaccination(s) and family history were not provided. On 17-Jul-2023, the patient received a dose of suspect diphtheria/tetanus/5 hybrid ac pertussis/ipv(vero)/hib(prp/t) vaccine Suspension for injection at dose of 0.5 ml (lot number: UJ757AAA, expiration date: 09-Sep-2023, strength, route, administration site: Unknown) for Immunization (immunisation) after it experienced a temperature excursion with no reported adverse event (poor quality product administered). No lab data reported. Action taken: not applicable. At time of reporting, the outcome was Unknown for the event pentacel was administered to a patient after it experienced a temperature excursion with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2564588

SANOFI PASTEUR · DTAP + IPV + HIB (PENTACEL) · Charge UJ757AAA

gering
Staat
MA
Alter
0,3
Geschlecht
F
Eingang
20.01.2023
Impfdatum
18.01.2023
Beginn
18.01.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect product formulation administered

Symptomtext

When the vaccine was administered only the solution containing IPV and DTaP was given, not the powder for the Hib.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect product formulation administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Covid 19 positive diagnosed 12/30/2022
Vorgeschichte
Formula intolerance; eczema
Andere Medikamente
-
Allergien
Possible dairy allergy
Vorherige Impfungen
-

VAERS 2409881

SANOFI PASTEUR · DTAP + IPV + HIB (PENTACEL) · Charge UJ757AAA

gering
Staat
NV
Alter
0,6
Geschlecht
F
Eingang
12.08.2022
Impfdatum
27.07.2022
Beginn
27.07.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered

Symptomtext

Patient received 2 doses HIB. Patient did not require treatment and had no adverse effects.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-